Corporate GovernanceOct 19, 2026, 05:16 PM
City Therapeutics Files Amended Certificate of Incorporation and Bylaws
AI Summary
City Therapeutics, Inc. has filed its amended and restated certificate of incorporation and bylaws in connection with its initial public offering. The changes include authorizing 500,000,000 shares of common stock, eliminating preferred stock references, authorizing 10,000,000 shares of undesignated preferred stock, and removing the ability for stockholders to act by written consent. The amended bylaws also establish procedures for stockholder meetings and advance notice for proposals.
Key Highlights
- City Therapeutics, Inc. filed amended and restated certificate of incorporation and bylaws.
- Authorized 500,000,000 shares of common stock.
- Eliminated all references to previously-existing series of preferred stock.
- Authorized 10,000,000 shares of undesignated preferred stock.
- Eliminated stockholders' ability to take action by written consent.
- Established advance notice procedure for stockholder proposals and nominations.
- Amended and restated bylaws became effective as of October 15, 2026.
Price Impact
More from CTY